-
No Fundamental Reason For Boston Scientific Shares' Underperformance, RBC Upgrades Stock
Friday, January 5, 2018 - 5:57pm | 402Read More...Shares of Boston Scientific Corporation (NYSE: BSX) have lost more than 6 percent over the past six months, which has at least one analyst suggesting investors take advantage of the underperformance. The Analyst RBC Capital Markets' Glenn Novarro upgraded Boston Scientific's stock ...
-
RBC Expects Strong Quarter From Medtronic
Thursday, May 12, 2016 - 10:45am | 357Read More...RBC expects a strong quarter from Medtronic PLC (NYSE: MDT) when it reports its fourth quarter results on May 31. Dublin, Ireland-based Medtronic makes medical devices such as pacemakers, implantable cardioverter defibrillators and drug delivery systems. Expectations For The Quarter "We expect a...
-
RBC Confident That Boston Scientific Is A Multi-Year Revenue Growth Story
Thursday, May 12, 2016 - 10:11am | 317Read More...Following a roadshow with CFO Dan Brennan of Boston Scientific Corporation (NYSE: BSX), RBC Capital’s Glenn Novarro expressed confidence regarding the company being a “multi-year revenue growth story, led by a deep pipeline.” Novarro maintains an Outperform rating on the company,...
-
Boston Scientific: RBC's Channel Checks Point To Upside Not Baked In Stock Price
Tuesday, April 12, 2016 - 9:55am | 277Read More...The launches of Synergy and Watchman by Boston Scientific Corporation (NYSE: BSX) appear ahead of plan. RBC Capital Markets’ Glenn Novarro maintained an Outperform rating for the company, while raising the price target from $20 to $22. Boston Scientific is a “multiyear growth story...
-
Boston Scientific Surges Following Watchman News
Monday, March 16, 2015 - 10:54am | 171Read More...Shares of Boston Scientific Corporation (NYSE: BSX) surged more than 3 percent Monday's following news that the company's Watchman device was approved by the U.S. FDA. According to RBC Capital Markets analysts Glenn Novarro, Watchman is a "novel left atrial appendage closure device...
-
RBC Analysts Comment On Intuitive Surgical
Wednesday, November 26, 2014 - 10:39am | 134Read More...On Wednesday, analysts at RBC commented on shares of Intuitive Surgical, Inc. (NASDAQ: ISRG). Glenn Novarro feels that “in the worst case scenario the company may witness 6%-8% of total procedures exposed to potential decline in useage of laparoscopic powered morcellators after FDA...
-
Johnson & Johnson Earnings Recap: Beats Estimates By Four Cents
Tuesday, January 21, 2014 - 3:49pm | 325Read More...On Tuesday morning, Johnson & Johnson (NYSE: JNJ) reported its fourth quarter results. The company announced an EPS of $1.24, beating the consensus estimate by four cents. Revenue of $18.40 billion came in $450 million higher than the consensus estimate. The company benefited from domestic...
-
Hologic Announced Stockholder Rights Plan
Thursday, November 21, 2013 - 2:34pm | 332Read More...Hologic (NASDAQ: HOLX) announced on Thursday that their Board of Directors unanimously adopted a one-year stockholder rights plan (the Rights Plan) following Carl Icahn's announcement that he intends to acquire an approximate 13 percent stake in the company. In the press release, the Rights Plan...
